We are live on
!
Find out more
SCV
Sands Capital Ventures Portfolio holdings
AUM
$614M
1-Year Est. Return
19.92%
This Fund
S&P 500
This Quarter
Est. Return
+15.1%
1 Year Est. Return
+19.92%
3 Year Est. Return
+166.76%
5 Year Est. Return
+157.76%
10 Year Est. Return
–
AUM
$415M
AUM Growth
+$55.2M
(+15%)
Cap. Flow
+$20.7M
Cap. Flow
% of AUM
4.99%
Top 10 Holdings %
Top 10 Hldgs %
98.85%
Holding
21
New
–
Increased
2
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Klaviyo
KVYO
|
+$81.3M |
| 2 |
Coupang
CPNG
|
+$24.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
+$48.4M |
| 2 |
DoorDash
DASH
|
+$9.45M |
| 3 |
Tarsus Pharmaceuticals
TARS
|
+$2.65M |
| 4 |
Snowflake
SNOW
|
+$44.2K |
| 5 |
Toast
TOST
|
+$39.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.72% |
| 2 | Financials | 26.34% |
| 3 | Consumer Discretionary | 17.42% |
| 4 | Healthcare | 13.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nu Holdings
NU
$73.6B
| $109M | 26.34% |
9,155,661
| – | – |
|
|
2
Klaviyo
KVYO
$5.26B
| $89.6M | 21.6% |
3,514,897
+3,043,637
| +646% | +$81.3M |
|
|
3
DoorDash
DASH
$94B
| $72M | 17.37% |
523,091
-80,197
| -13% | -$9.45M |
|
4
UiPath
PATH
$8.3B
| $52.2M | 12.59% |
2,303,452
| – | – |
|
|
5
Snowflake
SNOW
$114B
| $34.8M | 8.4% |
215,615
-228
| -0.1% | -$44.2K |
|
6
10x Genomics
TXG
$7.31B
| $18.1M | 4.36% |
481,770
| – | – |
|
7
Acumen Pharmaceuticals
ABOS
$193M
| $13.8M | 3.34% |
3,417,075
| – | – |
|
8
Acrivon Therapeutics
ACRV
$83.6M
| $11.8M | 2.85% |
1,652,605
| – | – |
|
|
9
Tarsus Pharmaceuticals
TARS
$3.04B
| $6.18M | 1.49% |
170,000
-90,000
| -35% | -$2.65M |
|
10
Taysha Gene Therapies
TSHA
$1.94B
| $2.08M | 0.5% |
724,873
| – | – |
|
11
908 Devices
MASS
$414M
| $1.79M | 0.43% |
237,258
| – | – |
|
12
Candel Therapeutics
CADL
$897M
| $1.28M | 0.31% |
811,737
| – | – |
|
|
SPRB
13
Spruce Biosciences
SPRB
$151M
| $622K | 0.15% |
10,493
| – | – |
|
14
Absci
ABSI
$1.58B
| $328K | 0.08% |
57,804
| – | – |
|
|
15
Coupang
CPNG
$29B
| $212K | 0.05% |
11,931
+1,480
| +14% | +$24.2K |
|
|
16
Toast
TOST
$20.1B
| $148K | 0.04% |
5,947
-1,918
| -24% | -$39.7K |
|
17
Samsara
IOT
$23.2B
| $135K | 0.03% |
3,570
| – | – |
|
18
Datadog
DDOG
$91.7B
| $125K | 0.03% |
1,015
| – | – |
|
19
CrowdStrike
CRWD
$221B
| $89.4K | 0.02% |
1,116
-260
| -19% | -$19.9K |
|
20
GitLab
GTLB
$7.2B
| $38.4K | 0.01% |
658
| – | – |
|
|
RYZB
21
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| – | – |
-778,922
| Closed | -$48.4M |
|
Similar funds
T2I
VAG
MKA
CSIA
ATFA
AA
FWM
FSA
Sands Capital Ventures's Q1 2024 Portfolio in Review
As of Q1 2024, Sands Capital Ventures held 21 positions worth $415M, up 15% from $359M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Sands Capital Ventures deployed $20.7M of net new capital in Q1 2024, adding to 2 existing holdings.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was DoorDash, an estimated $9.45M trimmed.
- Sands Capital Ventures added most to Klaviyo in Q1 2024, an estimated $81.3M increase.
- Sands Capital Ventures's biggest Q1 2024 reduction was DoorDash, cutting an estimated $9.45M.
- Sands Capital Ventures fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $48.4M.
- Sands Capital Ventures's ten largest holdings make up 99% of its $415M portfolio in Q1 2024.
- Sands Capital Ventures opened 0 new positions and closed 1 in Q1 2024.
- Sands Capital Ventures's portfolio value rose 15% quarter-over-quarter to $415M.
Based on Sands Capital Ventures's 13F filing for Q1 2024, filed 14 May 2024.